Skip to main navigation
  • News & Investors

    News & Investors

    • Press Releases
    • Financial Events
    • Scientific Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Analyst Coverage
    • Request Information
    • Investor FAQs
    • Investor Contact
  • Contact Us
Celsion
  • TECHNOLOGY
    • LTSL
    • TheraPlas
    • TheraSilence
  • PRODUCTS
    • ThermoDox
    • GEN-1
  • PIPELINE
    • Clinical Studies
    • Pre-clinical Programs
  • DISEASES
  • PUBLICATIONS
  • ABOUT US
    • Leadership
    • Board of Directors
    • Corporate Governance
Select Page

Board of Directors

    Investor Relations

    • News & Investors
    • Press Releases
    • Financial Events
    • Scientific Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
      • Insider Transactions
      • Stock Ownership
    • Financial Information
    • Stock Information
    • Analyst Coverage
    • Request Information
    • Investor FAQs
    • Investor Contact

Board of Directors

Show all
Michael H. Tardugno
Executive Chairman, President and Chief Executive Officer
Director Since 1/3/2007
Michael Tardugno
Director Since 1/3/2007

Mr. Tardugno's career has been exclusively focused in healthcare and brings over 29 years of experience in the pharmaceutical and medical device industries to Celsion. He has held positions of increasing responsibility in general management, operations, and product and technology development. Prior to joining the company in 2007, Mr. Tardugno served as Senior Vice President and General Manager of Mylan Technologies,Inc., a subsidiary of Mylan Laboratories, a transdermal delivery system and medical components company. Before Mylan, he was a founding member of management and Executive Vice President of Songbird Hearing, Inc., a privately held start-up company. Before Songbird, he held the positions of Senior Vice President of Technical Operations, World Wide for the ConvaTec division of Bristol-Myers Squibb, and World Wide Vice President of Technology Development and Manufacturing for Bausch & Lomb. Mr. Tardugno began his career in 1977 with Abbott Laboratories where he held positions in pharmaceutical operations and as plant manager for the company's Ross Laboratories Division nutritional business. Mr. Tardugno holds a B.S. in biology with a chemistry concentration from St. Bonaventure University and attended the Harvard Business School executive program.

Director Since
Jan 3, 2017
    Dr. Augustine Chow
    Director
    Director Since 3/1/2007
    Augustine Chow
    Director Since 3/1/2007

    Dr. Augustine Chow was appointed to the Board of Directors in March 2007.  Dr. Chow is the Chairman of Harmony Asset Management Limited in Hong Kong as well as a Director of Medifocus Inc. (TSX Venture: MFS).  From 1996-2015, Dr. Chow was the Chief Executive Officer of Harmony Asset Limited, a Hong Kong listed investment company. Between 2008 and 2016 he served as Executive Director of Kaisun Energy Group Limited.  From 1990 to 1998, Dr. Chow was the Chief Executive Officer of Allied Group of Companies based in Hong Kong which included a number of publicly-listed companies spanning various industries.  Prior to this, Dr. Chow held a senior position with Brunswick Corporation and Outboard Marine Corporation and was responsible for all business activities in South East Asia and China.  Dr. Chow has extensive experience in managing publicly-listed companies that are involved in manufacturing, marketing and financial services.  He specializes in mergers and acquisitions.  Dr. Chow’s qualifications include a number of Bachelors, Masters and Doctoral degrees.  Among these are a MSc from London Business School, a PhD from the University of South Australia, and an Engineering Doctorate and PhD on Biology from City University of Hong Kong.

    Director Since
    Mar 1, 2017
    Independent Director
    • Member of the Audit Committee
    • Member of the Compensation Committee
    Robert W. Hooper
    Director
    Director Since 8/01/2010
    Robert Hooper
    Director Since 8/01/2010

    Mr. Hooper currently serves as President of Crows Nest Ventures, Inc. and provides advisory and consulting services to the health care industry. From 1997-2001 he served as President North America for IMS Health, the global leader in health care information and market research. From 1993-1997 Mr. Hooper served as President of Abbott Laboratories Canada, based in Montreal. From 1989-1993 he served as Managing Director, Australia/Asia for Abbott Laboratories. Prior to 1989 Mr. Hooper served as Director of Manufacturing and Plant Manager for Abbott's Nutritional and Hospital Products Divisions. Mr. Hooper began his career with E.R. Squibb and Sterling Winthrop Labs. He received a B.A. in Biology from Wilkes University and currently resides in Naples, FL with his wife Cynthia.

    Director Since
    Aug 1, 2010
    Independent Director
    • Chair of the Compensation Committee
    Dr. Alberto Martinez
    Director
    Director since 12/06/2010
    Alberto Martinez
    Director since 12/06/2010

    Dr. Alberto Martinez most recently served as the President and Chief Executive Officer of Talecris Biotherapeutics, one of the leading producers of plasma-derived therapeutic proteins in the world. Prior to joining Talecris, Dr. Martinez served as Executive Vice President of Worldwide Commercial Operations for CSL Behring, the company formed with the acquisition of Aventis Behring by Australian company CSL in 2004. He was Vice President and General Manager for Emerging Markets for Aventis Behring from 1996-2000 and served as President of Aventis BioServices from 2000-2004. Dr. Martinez began his career with Sandoz Ltd., today Novartis. He spent twenty years working with the company in a variety of roles across the world, such as Director and Head of Corporate Strategic Planning in the United States, Head of the Latin America Business Operations in Switzerland, Director of Marketing and Sales in Spain, and Head of Marketing and Clinical Research in Brazil. Dr. Martinez is originally from Brazil and holds an MD from the University of Sao Paulo.

    Director Since
    Dec 6, 2010
    Independent Director
    • Member of the Audit Committee
    • Member of the Compensation Committee
    • Member of the Nominating and Governance Committee
    Frederick J. Fritz
    Director
    Director since 07/08/2011
    Frederick Fritz
    Director since 07/08/2011

    Mr. Fritz is currently the CEO & Founder of NeuroDx, a development stage diagnostic device company focused on the neurosurgery market. Mr. Fritz joined NeuroDx from Valeo Medical, a biotech company he founded in 2003 to develop the world's first non-invasive diagnostic test for endometriosis. Prior to that, Mr. Fritz was President and CEO of Songbird Hearing, a medical device spin out of Sarnoff Corp. He is a University of Illinois engineer (summa cum laude) and a Harvard MBA. Mr. Fritz began his career in marketing management and new product development. He joined Schering Plough's Wesley Jessen in 1985 as VP Marketing and Sales in 1986. He was promoted to general manager of Schering's Over the Counter pharmaceutical business in 1988 and of the podiatric products business in 1990. He was President of Coleman North America from 1995-1997. He lives outside Princeton NJ with his wife, Helen, and two teenage daughters, Erika and Jenna.

    Director Since
    Jul 8, 2011
    Independent Director
    • Chair of the Audit Committee
    • Chair of the Nominating and Governance Committee
    Donald Braun Ph.D.
    Director
    Director Since 12/15/2015
    Donald Braun
    Director Since 12/15/2015

    Dr. Braun joined Celsion in 2015 and brings over 30 years of research expertise in oncology, with a focus on immunotherapy and the effectiveness and impact of chemotherapy protocols on various cancers and tumor types. Prior to his retirement in 2016 Dr. Braun served as Vice President Translational Research and Chief Science Officer at the Cancer Treatment Centers of America. Prior to the CTCA, he was the Scientific Director of the Cancer Center and Professor of Medicine and Immunology at Rush Medical College in Chicago, and the Administrative Director of the Cancer Institute and a Professor of Surgery with tenure at the Medical College of Ohio.  Dr. Braun has been appointed to and served on more than a dozen federal government and public advisory committees on oncology and immunology. He received his Ph.D. in Immunology and Microbiology from the University of Illinois at the Medical Center in Chicago.

    Director Since
    Dec 15, 2015
    Independent Director
    • Member of the Science and Technology
    Andreas Voss MD
    Director
    Director Since 12/15/2015
    Andreas Voss
    Director Since 12/15/2015

    Dr. Voss joined Celsion in 2015 and currently serves as Vice President of Clinical Affairs in Europe at Caris Life Sciences, a biotechnology company focused on implementing personalized medicine in oncology through its liquid biopsy technology. Prior to joining Caris in 2010, he was responsible for the global clinical development of Avastin® and a member of the Corporate Drug Safety Board at F. Hoffmann-La Roche. Before joining Roche in 2006, he was Medical Director for the Lung Cancer Disease Area at AstraZeneca, and from 2000 to 2003, he was the Medical Director for Anti-infectives and Oncology atBayer GmbH.  From 1996 to 2000, Dr. Voss was Head of Medical Research, Oncology at Asta Medica AG. Dr. Voss received his M.D. from the University of Hamburg Medical School and was a postdoctoral fellow at the University of California at San Diego. He is board certified in internal medicine

    Director Since
    Dec 15, 2015
    Independent Director
    • Chair of the Science and Technology

    For recent transactions, including derivative transactions, see our Section 16 SEC filings page.

      Shareholder Tools

      • Printed Materials
      • Email Alerts
      • Downloads
      • RSS
      • Print
      • Search

      • Facebook
      • Google
      • LinkedIn
      • Twitter
      • RSS

    Home

    Technology

    Products

    Pipeline

    Disease

    Publications

    News & Investors

    About Us

    Careers

    Privacy Policy

      ThermoDox is a registered trademark of Celsion Corporation.
      TheraPlas and TheraSilence are trademarks of Celsion Corporation.
      Avastin is a registered trademark of Genentech, Inc.
      Copyright © 2018 Celsion Corporation. All rights reserved.

      Share This
      • Twitter
      • Google+
      • Facebook
      • LinkedIn